Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#218 of 388

Li Watsek

Cantor Fitzgerald · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Jun 2025

Analyst rating accuracy & track record

Li Watsek is an equity research analyst at Cantor Fitzgerald. Quantellect has scored 22 of their stock calls across 9 companies. Their picks beat their sector 38% of the time over the next 12 months, and their price targets were reached of the time within a year.

Win % vs sector
38%
PT Hit % (12mo)
Avg sector-excess
−7.8%
Scored calls
22
Tickers
9
Tier
Provisional

Track record

Quantellect has scored 22 of Li Watsek's stock calls across 9 companies, dating back to 2021. Their rated stocks beat their own sector 38% of the time over the next 12 months. On a typical call, a Watsek pick returned −7.8% more than its sector over the following year.

Of the scored calls, 22 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
KURAKura Oncology Inc
BuyJun 2025+71.0%
KURAKura Oncology Inc
BuyJun 2025+71.0%
REPLReplimune Group Inc
BuyJun 2025+6.1%
CRVSCorvus Pharmaceuticals Inc
BuyJun 2025+169.7%
ZLABZai Lab Ltd
BuyMar 2025−52.6%
ACRVAcrivon Therapeutics, Inc. Common Stock
BuyMar 2025−46.0%
TARAProtara Therapeutics Inc
BuyMar 2025+17.9%
ACRVAcrivon Therapeutics, Inc. Common Stock
BuyJan 2025−75.0%
ALXOAlx Oncology Holdings 
BuyJan 2025−13.9%
ALXOAlx Oncology Holdings 
BuyDec 2024−19.7%
KURAKura Oncology Inc
BuyDec 2024−2.2%
KURAKura Oncology Inc
BuyNov 2024−2.4%
ALXOAlx Oncology Holdings 
BuyNov 2024−10.4%
ALXOAlx Oncology Holdings 
BuyAug 2024−64.9%
ALXOAlx Oncology Holdings 
BuyMay 2024−90.6%
CRISCuris Inc
BuyMay 2024−74.9%
ALXOAlx Oncology Holdings 
BuyApr 2024−97.7%
CRVSCorvus Pharmaceuticals Inc
BuyApr 2024+69.4%
CRVSCorvus Pharmaceuticals Inc
Buy$4.00Sep 2023+111.8%Hit
CRVSCorvus Pharmaceuticals Inc
Buy$4.00May 2023+5.9%Hit
FATEFate Therapeutics Inc
Buy$45.00Nov 2022−85.8%Miss
CRVSCorvus Pharmaceuticals Inc
Buy$8.00Dec 2021−74.7%Miss
Go to

Li Watsek: analyst track record FAQ

Is Li Watsek a good stock analyst?

Yes, by track record. Li Watsek ranks number 218 of 388 of the analysts Quantellect scores, with a Q Score of 27 out of 100. Past results do not guarantee future ones.

What is Li Watsek's win rate?

Li Watsek's win rate is 38%. Across 22 scored calls, their rated stocks beat their sector 38% of the time over the next 12 months. On a typical call they returned −7.8% more than the sector.

What stocks and sectors does Li Watsek cover?

Li Watsek covers 9 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Li Watsek's price targets accurate?

Li Watsek's price targets are reached within 12 months — of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Li Watsek's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Li Watsek rank among Wall Street analysts?

Li Watsek ranks number 218 of 388 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.